Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000935
Chunk: 43

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 43
---
 that the Company shall not be obligated
to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction
in which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise
so subject.

(c) .
The Company shall use its commercially reasonable efforts to promptly secure the listing of all of the Purchase Shares and Commitment
Shares, if any, to be issued to the Investor hereunder on the Principal Market (subject to official notice of issuance) and upon each
other national securities exchange or automated quotation system, if any, upon which the Depositary Shares are then listed, and shall
use commercially reasonable efforts to maintain, so long as any Depositary Shares shall be so listed, such listing of all such Securities
from time to time issuable hereunder. The Company shall use commercially reasonable efforts to maintain the listing of the Depositary
Shares on the Principal Market and shall comply in all respects with the Company’s reporting, filing and other obligations under
the bylaws or rules and regulations of the Principal Market. Neither the Company nor any of its Subsidiaries shall take any action that
would reasonably be expected to result in the delisting or suspension of the Depositary Shares on the Principal Market. The Company shall
promptly, and in no event later than four (4) Business Days after receipt, provide to the Investor copies of any notices it receives from
any Person regarding the continued eligibility of the Depositary Shares for listing on the Principal Market; provided, however, that the
Company shall not be required to provide the Investor copies of any such notice that the Company reasonably believes constitutes material
non-public information and the Company would not be required to publicly disclose such notice in any report or statement filed with the
SEC and under the Exchange Act or the Securities Act. Notwithstanding the foregoing, the requirements of this Section 5(c) shall be satisfied
to the extent that the contents of such notice are made available through a document filed by the Company with the SEC and available on
the SEC’s EDGAR system (or any successor thereto) within the required time period. The Company shall pay all fees and expenses in
connection with satisfying its obligations under this . The Company shall take commercially reasonable actions necessary
to ensure that its Depositary Shares can be transferred electronically as DWAC Shares.

| -22- |

(d) . The Investor agrees that beginning on the date of this Agreement